Citadel Advisors - AMICUS THERAPEUTICS INC ownership

AMICUS THERAPEUTICS INC's ticker is and the CUSIP is 03152W959. A total of 4 filers reported holding AMICUS THERAPEUTICS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of AMICUS THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$93,000
-17.0%
17,000
+28.8%
0.00%
Q1 2016$112,000
-8.2%
13,200
+4.8%
0.00%
Q4 2015$122,000
-33.3%
12,600
-3.8%
0.00%
Q3 2015$183,000
-25.3%
13,100
-24.3%
0.00%
Q2 2015$245,000
-57.5%
17,300
-67.4%
0.00%
-100.0%
Q1 2015$577,000
+63.5%
53,000
+25.0%
0.00%
Q4 2014$353,000
+72.2%
42,400
+23.3%
0.00%
Q3 2014$205,000
+925.0%
34,400
+309.5%
0.00%
Q4 2013$20,000
+33.3%
8,400
+31.2%
0.00%
Q3 2013$15,000
-31.8%
6,400
-33.3%
0.00%
Q2 2013$22,0009,6000.00%
Other shareholders
AMICUS THERAPEUTICS INC shareholders Q4 2014
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 28,500$658,0000.00%
JPMORGAN CHASE & CO 372,500$8,601,0000.00%
SIMPLEX TRADING, LLC 233$537,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of AMICUS THERAPEUTICS INC shareholders